Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal
(By Adam Feurerstein and Matthew Herper for STAT) In a blockbuster deal between two of biopharma’s largest players, Bristol-Myers Squibb
Read More(By Adam Feurerstein and Matthew Herper for STAT) In a blockbuster deal between two of biopharma’s largest players, Bristol-Myers Squibb
Read More(By Alia Paavola for Becker’s Hospital Review) The U.S. Supreme Court will consider a case next week that examines a
Read More(By Shefali Luthra for Kaiser Health News) It used to be the stuff of stoner comedies and “Just Say No”
Read More(By Nicholas Florko for STAT) WASHINGTON —The drug industry’s storied lobbying group isn’t accustomed to bad news — and with
Read More(By Harrison Cook for Becker’s Hospital Review) U.S. children and adolescents are increasingly dying from opioid overdoses, according to a study
Read More(By Ike Swetlitz for STAT) A federal judge has blocked a Trump administration policy that reduces payments to hospitals under
Read More(By Harrison Cook for Becker’s Hospital Review) Taking long-term opioid users off their prescription painkillers may be harmful, international health
Read MoreAfter temporarily holding off on increases as a result of federal pressure, several dozen pharmaceutical companies are planning to raise their
Read More(By Alia Paavola for Becker’s Hospital Review) Walgreens and Verily, Alphabet’s life sciences unit, will team up to improve health outcomes and
Read More(By Sarah Jane Tribble for Kaiser Health News) Europeans have found the secret to making some of the world’s costliest
Read More